Hims (and its women-focused sister brand, Hers) remains one of the largest consumer telehealth platforms offering GLP-1 weight loss medication, alongside dozens of other health categories. This page covers the most notable 2026 program developments and how Hims's pricing compares to medication-focused providers like Luma Health. Hims and Luma Health are completely separate, unaffiliated companies.
Hims 2026: Expanded Women's Health Plus Continued GLP-1 Pricing
Hims has spent the past several years building out from its original men's-health focus into a much broader consumer health platform, and 2026 has continued that trajectory. Rather than a single dramatic overhaul, Hims's changes this year have largely been incremental: expanding adjacent categories, adjusting plan tiers, and continuing to operate GLP-1 weight loss as one offering among many rather than as a specialized focus area.
Women's Health Expansion
Hims has significantly expanded Hers, the women-focused brand, to include broader hormone therapy and women's metabolic health offerings alongside GLP-1 medications. For patients who want a single platform covering both weight management and other women's health needs, this consolidation has genuine appeal — though it doesn't necessarily translate into lower GLP-1 pricing specifically.
Pricing Adjustments
Hims GLP-1 pricing remains in the $199–$249/month range for compounded semaglutide and tirzepatide, with some plan tier adjustments throughout 2026. As with most large platforms, exact pricing can vary by region, current promotions, and which specific plan a patient is steered toward during intake — always confirm the actual ongoing monthly cost before committing, not just an introductory rate.
Continued Multi-Category Platform Model
Hims continues to operate as a general multi-health-category platform — weight loss is one of dozens of health categories the company addresses, alongside hair loss, mental health, sexual health, skincare, and primary care. This means the GLP-1 clinical team isn't exclusively focused on metabolic health, which is a meaningful structural difference from specialist providers.
Compounded Medication Access
Hims continues offering compounded semaglutide at approximately $199/month and tirzepatide at approximately $199–$249/month — both significantly higher than flat-fee specialists, though broadly in line with where Hims has priced these medications for the past couple of years.
What Hasn't Changed: The Core Cost Comparison
The fundamental Hims-versus-specialist-provider comparison hasn't shifted much despite the 2026 updates. Hims still charges $199–$249/month for compounded GLP-1 medication that Luma Health delivers for $90–$165/month. The cost premium at Hims pays primarily for brand advertising, a multi-category platform, and general telehealth infrastructure — not for a meaningfully different or more effective medication.
| Factor | Hims (2026) | Luma Health |
|---|---|---|
| Semaglutide monthly cost | $199/mo | $90/mo flat |
| Tirzepatide monthly cost | $199–$249/mo | $165/mo flat |
| Annual cost (semaglutide) | $2,388/yr | $1,080/yr |
| Annual savings with Luma Health (sema) | — | $1,308/yr |
| Annual savings with Luma Health (tirz) | — | $408–$1,008/yr |
| Platform focus | General multi-category telehealth | GLP-1 weight loss specialist |
| Clinical provider | Multi-specialty network | Wasef Health, PC (metabolic health focus) |
At $199/month for semaglutide, Hims costs $2,388/year. At $199–$249/month for tirzepatide, Hims costs $2,388–$2,988/year. Compared to Luma Health at $1,080/year (semaglutide) or $1,980/year (tirzepatide), the gap is $1,308/year on semaglutide and $408–$1,008/year on tirzepatide for what is, at the molecular level, the same general category of compounded medication.
Why a Multi-Category Platform Costs More for GLP-1 Specifically
It's worth understanding why a large, diversified platform like Hims tends to charge more for GLP-1 medication than a specialist does, since the reasoning applies broadly across the telehealth industry, not just to Hims. Multi-category platforms carry significant overhead from national advertising campaigns, a broad clinical network spanning dozens of unrelated conditions, and a consumer brand built around recognition rather than deep clinical specialization in any one area. None of that overhead is inherently bad — it's part of what makes Hims accessible and familiar to a huge number of patients — but it does get reflected in pricing across every category the platform touches, GLP-1 included.
A specialist provider like Luma Health, by contrast, has lower acquisition costs, a narrower and more deeply specialized clinical focus, and pricing built around the realistic cost of delivering one category of treatment well, rather than subsidizing a portfolio of dozens of unrelated health services.
Clinical and Regulatory Trust Framework
Regardless of which provider you choose, GLP-1 therapy is governed by the same clinical eligibility standards. Understanding this baseline helps you evaluate whether any provider's intake process — Hims included — is appropriately rigorous.
Eligibility Criteria
Licensed clinicians evaluate eligibility using FDA-aligned criteria: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease.
Contraindications
Personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding are standard contraindications screened at intake by any reputable provider.
Luma Health's Clinical Infrastructure
Luma Health's prescribing clinicians operate through Wasef Health, PC, and compounded medications are dispensed by VialsRX, a licensed 503A sterile compounding pharmacy based in Houston, TX. Both the clinical and pharmacy sides of any GLP-1 provider should be independently verifiable.
💡 Is Hims better than Luma Health for women's health? Hers, Hims's women-focused brand, has expanded women's health offerings including hormone therapy alongside GLP-1. Luma Health also offers Women's Hormone Therapy at $100/month. For combined GLP-1 plus women's hormone therapy needs, compare the all-in cost at each platform and exactly what clinical services are included before deciding.
What Patients Should Verify Before Choosing Any Provider
Whether you're considering Hims, Luma Health, or any other GLP-1 telehealth provider, a few questions consistently separate transparent operators from less transparent ones: Is the advertised price the actual ongoing monthly cost, or a promotional rate that expires? Does the platform publicly name its compounding pharmacy and that pharmacy's license number? Are the prescribing clinicians US-licensed with verifiable credentials? Is the GLP-1 program staffed by clinicians with metabolic health focus, or folded into a much broader general practice? None of these questions disqualify a large platform like Hims automatically, but they're worth asking before you commit to a monthly subscription.
Sources & References
- Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice. DOI: 10.4158/EP161365.GL
- American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. DOI: 10.1161/CIR.0000000000000973
- Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. JCEM. DOI: 10.1210/jc.2014-3415
- FDA BeSafeRx guidance on verifying online pharmacy legitimacy. fda.gov.
Frequently Asked Questions
Hims invests heavily in brand advertising (TV, digital, social media) and operates a complex multi-category platform spanning dozens of health conditions. These operational costs are reflected in their pricing across every category, including GLP-1. The actual compounded medication quality and general clinical oversight model are broadly comparable to lower-cost specialist providers; you're paying a meaningful premium for the Hims brand and platform breadth.
Hims has made incremental pricing adjustments through 2026, with current tirzepatide pricing ranging $199–$249/month depending on plan tier. Confirm current Hims pricing directly on their website, as prices change frequently and can vary by region and current promotions. For consistent flat pricing, Luma Health at $165/month all-inclusive is the more predictable option.
Hers (Hims's women-focused brand) has expanded women's health offerings including hormone therapy alongside GLP-1. Luma Health also offers Women's Hormone Therapy at $100/month. For combined GLP-1 plus women's hormone therapy, compare the all-in cost at each platform and what clinical services are included before choosing.
Weight loss is one of dozens of health categories Hims addresses, alongside hair loss, sexual health, mental health, skincare, and primary care. The clinical team handling GLP-1 prescriptions is part of a broader multi-specialty network rather than a team focused exclusively on metabolic and weight health. Specialist providers like Luma Health, by contrast, build their entire clinical model around GLP-1 and metabolic health.
Yes. Hims is a large, publicly traded telehealth company using licensed clinicians and FDA-registered compounding pharmacies. The comparison to Luma Health in this article is about cost and specialization, not legitimacy — both are real medical services delivering real medications.
Switching from Hims to Luma Health saves approximately $1,308/year on semaglutide ($199/mo vs. $90/mo) and $408–$1,008/year on tirzepatide ($199–$249/mo vs. $165/mo flat), for the same general category of compounded medication. Always confirm your specific current Hims plan pricing before calculating exact savings, since pricing varies by tier and promotion.